![Towards a Molecular Definition of Enterohemorrhagic Escherichia coli (EHEC): Detection of Genes Located on O Island 57 as Markers To Distinguish EHEC from Closely Related Enteropathogenic E. coli Strains | Journal of Towards a Molecular Definition of Enterohemorrhagic Escherichia coli (EHEC): Detection of Genes Located on O Island 57 as Markers To Distinguish EHEC from Closely Related Enteropathogenic E. coli Strains | Journal of](https://jcm.asm.org/content/jcm/51/4/1083/F1.large.jpg)
Towards a Molecular Definition of Enterohemorrhagic Escherichia coli (EHEC): Detection of Genes Located on O Island 57 as Markers To Distinguish EHEC from Closely Related Enteropathogenic E. coli Strains | Journal of
![COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study - The Lancet Rheumatology COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study - The Lancet Rheumatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8dd76854-961f-4494-b615-5c56d6463230/gr1.jpg)
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study - The Lancet Rheumatology
![Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb1467c8-51ef-4a3a-85e8-3143959f4215/gr1_lrg.jpg)
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology
![Early-drug development in the era of immuno-oncology: are we ready to face the challenges? - Annals of Oncology Early-drug development in the era of immuno-oncology: are we ready to face the challenges? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f98952b7-ba02-4036-bf93-f9838e82eec3/gr1.jpg)